Next earnings date: 28 Oct 2025
CONMED Corporation – NYSE:CNMD
CONMED stock price today
$54.5
-16.12
-22.83%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
CONMED stock price monthly change
+3.34%
month
CONMED stock price quarterly change
+3.34%
quarter
CONMED stock price yearly change
-37.09%
year
CONMED key metrics
Market Cap | 2.11B |
Enterprise value | 3.08B |
P/E | 16.54 |
EV/Sales | 2.39 |
EV/EBITDA | 12.50 |
Price/Sales | 1.69 |
Price/Book | 2.33 |
PEG ratio | -1.70 |
EPS | 2.69 |
Revenue | 1.26B |
EBITDA | 173.62M |
Income | 82.34M |
Revenue Q/Q | 5.47% |
Revenue Y/Y | 14.77% |
Profit margin | 10.24% |
Oper. margin | 14.63% |
Gross margin | 54.31% |
EBIT margin | 14.63% |
EBITDA margin | 13.77% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCONMED stock price history
CONMED stock forecast
CONMED financial statements
| Jun 2023 | 317.65M | 13.73M | 4.32% |
|---|---|---|---|
| Sep 2023 | 304.57M | 15.83M | 5.2% |
| Dec 2023 | 327.04M | 33.07M | 10.11% |
| Mar 2024 | 311.63M | 19.70M | 6.32% |
| Sep 2025 | 365.24M | 45.24M | 12.39% |
|---|---|---|---|
| Oct 2025 | 361.29M | 45.03M | 12.46% |
| Dec 2025 | 388.27M | 53.05M | 13.67% |
| Mar 2026 | 354.58M | 37.42M | 10.55% |
Analysts Price target
Financials & Ratios estimates
| 2024-10-30 | 0.99 | 1.05 |
|---|
1.13%
Yield TTM
| Payout ratio | 18.69% |
|---|
| 2019 | 0.71% |
|---|---|
| 2020 | 0.71% |
| 2021 | 0.56% |
| 2022 | 0.9% |
| 2023 | 0.73% |
| Jun 2023 | 2322722000 | 1.54B | 66.41% |
|---|---|---|---|
| Sep 2023 | 2325675000 | 1.52B | 65.76% |
| Dec 2023 | 2300021000 | 1.46B | 63.73% |
| Mar 2024 | 2309255000 | 1.45B | 62.99% |
| Jun 2023 | 26.67M | -5.52M | -19.78M |
|---|---|---|---|
| Sep 2023 | 46.12M | -5.39M | -37.22M |
| Dec 2023 | 56.39M | -4.85M | -58.76M |
| Mar 2024 | 29.12M | -2.03M | -17.01M |
CONMED alternative data
| Aug 2023 | 4,100 |
|---|---|
| Sep 2023 | 4,100 |
| Oct 2023 | 4,100 |
| Nov 2023 | 4,100 |
| Dec 2023 | 4,100 |
| Jan 2024 | 4,100 |
| Feb 2024 | 4,100 |
| Mar 2024 | 4,000 |
| Apr 2024 | 4,000 |
| May 2024 | 4,000 |
| Jun 2024 | 4,000 |
| Jul 2024 | 4,000 |
CONMED other data
100.00%
+3.58%
of CNMD is owned by hedge funds
217
-54
31.99M
-1.90M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2023 | 0 | 1355 |
| Sep 2023 | 0 | 2000 |
| Nov 2023 | 0 | 1200 |
| Dec 2023 | 0 | 2300 |
| Apr 2024 | 3000 | 0 |
| May 2024 | 4792 | 0 |
| Jun 2024 | 0 | 4000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | GLAZE RICHARD officer: Chief Information Offi.. | RSUs (Restricted Stock Units) | 375 | N/A | N/A | ||
Option | GLAZE RICHARD officer: Chief Information Offi.. | Common Stock | 375 | N/A | N/A | ||
Option | HARTMAN CURT R director, officer.. | SARs (Stock Appreciation Rights) | 30,000 | $51.3 | $1,539,000 | ||
Option | HARTMAN CURT R director, officer.. | Common Stock | 30,000 | $51.3 | $1,539,000 | ||
Option | FARKAS CHARLES director | Common Stock | 1,000 | $39.64 | $39,640 | ||
Option | FARKAS CHARLES director | SARs (Stock Appreciation Rights) | 1,000 | $39.64 | $39,640 | ||
Option | CLIFFORD EDWARD A. officer: VP Global Manufacturing | Rsus (restricted Stock Units) | 500 | N/A | N/A | ||
Option | CLIFFORD EDWARD A. officer: VP Global Manufacturing | Common Stock | 500 | N/A | N/A | ||
Option | PETERS STANLEY W III officer: Presiden.. | Common Stock | 4,000 | $41.93 | $167,720 | ||
Sale | PETERS STANLEY W III officer: Presiden.. | Common Stock | 4,000 | $71.82 | $287,280 |
| Patent |
|---|
Grant Filling date: 12 Nov 2019 Issue date: 23 Aug 2022 |
Grant Filling date: 26 Oct 2017 Issue date: 23 Aug 2022 |
Grant Filling date: 8 Oct 2019 Issue date: 9 Aug 2022 |
Application Filling date: 2 Jul 2020 Issue date: 4 Aug 2022 |
Application Filling date: 27 Mar 2020 Issue date: 4 Aug 2022 |
Grant Filling date: 4 Jun 2020 Issue date: 2 Aug 2022 |
Grant Utility: Gas circulation system with gas sealed access cap and valve sealed access cap for robotically assisted surgical procedures Filling date: 25 Mar 2020 Issue date: 2 Aug 2022 |
Application Filling date: 15 Jul 2021 Issue date: 28 Jul 2022 |
Application Filling date: 7 Jun 2021 Issue date: 28 Jul 2022 |
Application Filling date: 17 Feb 2021 Issue date: 28 Jul 2022 |
| Quarter | Transcript |
|---|---|
| Q1 2024 25 Apr 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 31 Jan 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 25 Oct 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 26 Jul 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Curt R. Hartman (1964) Chairman, Chief Executive Officer & Pres | $1,790,000 |
Mr. Patrick J. Beyer (1966) Pres of International & Global Orthopedics | $932,460 |
| Mr. Todd W. Garner (1969) Executive Vice President & Chief Financial Officer | $826,500 |
| Mr. Stanley W. Peters III (1975) Vice President & GM of U.S. Advanced Surgical | $620,750 |
| Mr. John E. Kennedy (1958) Group Executive Vice President of Advanced Endoscopic Technologies, QA/RA, Distribution & Customer Service | $572,930 |
Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business
Conmed: Updated Guidance Is Positive
Why InMode Deserves A Spot In Your 2023 Portfolio
ConMed: Still Fairly Priced, Turning More Constructive
Red Hot Inflation: Healthcare Stocks You Can Buy
Stocks With The Best History Of Beating Estimates
-
What's the price of CONMED stock today?
One share of CONMED stock can currently be purchased for approximately $54.5.
-
When is CONMED's next earnings date?
CONMED Corporation is estimated to report earnings on Tuesday, 28 Oct 2025.
-
Does CONMED pay dividends?
Yes, CONMED pays dividends and its trailing 12-month yield is 1.13% with 19% payout ratio. The last CONMED stock dividend of $0.2 was paid on 5 Jan 2022.
-
How much money does CONMED make?
CONMED has a market capitalization of 2.11B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 19.06% to 1.24B US dollars. CONMED earned 64.46M US dollars in net income (profit) last year or $1.05 on an earnings per share basis.
-
What is CONMED's stock symbol?
CONMED Corporation is traded on the NYSE under the ticker symbol "CNMD".
-
What is CONMED's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of CONMED?
Shares of CONMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are CONMED's key executives?
CONMED's management team includes the following people:
- Mr. Curt R. Hartman Chairman, Chief Executive Officer & Pres(age: 61, pay: $1,790,000)
- Mr. Patrick J. Beyer Pres of International & Global Orthopedics(age: 59, pay: $932,460)
- Mr. Todd W. Garner Executive Vice President & Chief Financial Officer(age: 56, pay: $826,500)
- Mr. Stanley W. Peters III Vice President & GM of U.S. Advanced Surgical(age: 50, pay: $620,750)
- Mr. John E. Kennedy Group Executive Vice President of Advanced Endoscopic Technologies, QA/RA, Distribution & Customer Service(age: 67, pay: $572,930)
-
How many employees does CONMED have?
As Jul 2024, CONMED employs 4,000 workers.
-
When CONMED went public?
CONMED Corporation is publicly traded company for more then 38 years since IPO on 23 Jul 1987.
-
What is CONMED's official website?
The official website for CONMED is conmed.com.
-
Where are CONMED's headquarters?
CONMED is headquartered at 11311 Concept Boulevard, Largo, FL.
-
How can i contact CONMED?
CONMED's mailing address is 11311 Concept Boulevard, Largo, FL and company can be reached via phone at +7 273926464.
CONMED company profile:
CONMED Corporation
conmed.comExchange:
NYSE
Full time employees:
4,000
Industry:
Medical - Devices
Sector:
Healthcare
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
11311 Concept Boulevard
Largo, FL 33773-4908
Largo, FL 33773-4908
CIK: 0000816956
ISIN: US2074101013
CUSIP: 207410101
